For companies choosing to outsource manufacturing, selection of the right CMO (Contract Manufacturing Organization) is critical. The client requested DHC’s assistance in selecting a CMO that would provide a clear path through commercialization for their preclinical stage gene therapy program.
The output of this project was the selection of a CMO that would meet the client’s needs both today and in the future. DHC was able to deliver on the client’s need for a rapid decision-making process by assessing manufacturers on parallel tracks, receiving expedited responses (due to both reputation and industry relationships), and leveraging prior experience to speed RFP preparation and response review. Ultimately, the impact for the client was the identification of and beginning of a relationship with a CMO that will suit their needs for years to come.